SAKAKIBARA MAYA
- 助教
- 学位：修士（看護学）
基本情報
所属
- Undergraduate School of Medicine / Faculty of Nursing
詳細情報
論文
Immune-related adverse event detection in liver cancer patients treated with immune checkpoint inhibitors: Nationwide exploratory survey in Japan.
Impact of Atezolizumab + Bevacizumab Therapy on Health-Related Quality of Life in Patients with Advanced Hepatocellular Carcinoma.
講演・口頭発表等
- Reduced health-related quality of life predicts unfavorable outcomes in patients with advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab
- Reduced health-related quality of life predicts poor outcomes in advanced hepatocellular carcinoma patients treated with atezolizumab and bevacizumab
- Analysis of predictors for clinical outcomes focusing on health-related quality of life in patients with advanced hepatocellular carcinoma who received atezolizumab and bevacizumab combination therapy
ResearchMapへ移動します
Contact Us
Inquiries about coverage
Public Affairs Division Public Affairs and Communications Department
Tel. 0463-63-4670（direct dialing）